The largest multi-cancer screening trial in history missed its primary goal. The FDA panel voted 7 to 2 to approve anyway. Here is what the evidence actually shows and what health systems need to plan for.
142,250 People, One Missed Endpoint: What the FDA Galleri Vote Actually Tells Us
The largest multi-cancer screening trial in history missed its primary goal. The FDA panel voted 7 to 2 to approve anyway. Here is what the evidence actually shows and what health systems need to plan for.
